<?xml version="1.0" encoding="UTF-8"?>
<p id="Par16">There were no statistically significant differences in change in EQ-5D overall index scores over time between the group receiving no maintenance therapy and the groups receiving any maintenance (
 <italic>P</italic> = 0.98) or lenalidomide-only maintenance therapy (
 <italic>P</italic> = 0.46; Fig. 
 <xref rid="Fig6" ref-type="fig">6</xref>a, b; Table 7 [Online Resource 
 <xref rid="MOESM1" ref-type="media">1</xref>]). Across groups, EQ-5D overall index score increased significantly from pre-ASCT to the follow-up period (
 <italic>P</italic> &lt; 0.001 for all groups) and decreased at progression (Fig. 
 <xref rid="Fig1" ref-type="fig">6</xref>c). The decrease at progression reached statistical significance in the groups receiving lenalidomide-only maintenance therapy (
 <italic>P</italic> = 0.001; Fig. 
 <xref rid="Fig6" ref-type="fig">6</xref>c) and no maintenance therapy (
 <italic>P</italic> = 0.049).
</p>
